KUALA LUMPUR: The administration of Pfizer BioNTech Covid-19 vaccine to children under the age of 12 will begin in 2022, according to the Health Ministry (MOH).
MOH said that currently, only the Pfizer-BioNTech Covid-19 vaccine is available for use in children below 12 and it is awaiting regulatory approval from the European Union and the United States.
Already a subscriber? Log in
The Star 6.6 DEAL: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
